CAR T

Juno boosted by CAR-T trial findings in NHL

https://pharmaphorum.com/news/juno-boosted-car-t-trial-findings-nhl/

Kite in CAR-T pole position as rolling submission begins

https://pharmaphorum.com/news/kite-says-on-track-for-2017-car-t-therapy-launch/

Kite outlines vision for next gen cancer killing cells

https://pharmaphorum.com/news/kite-outlines-vision-next-gen-cancer-killing-cells/

The next step in the fight against cancer: Making CAR-T a viable option

https://pharmaphorum.com/partner-content-oncology/car-t-cells-a-turning-point-in-the-fight-against-cancer/

Kite lifted by CAR-T success in lymphoma

https://pharmaphorum.com/news/kite-lifted-car-t-success-lymphoma/

Novartis committed to CAR-Ts – but doubts about commercial viability remain

https://pharmaphorum.com/views-and-analysis/will-car-t-profitable-pharma/

Novartis move damages CAR-T confidence

https://pharmaphorum.com/news/novartis-damages-confidence-car-t/

Novartis on track to bring first CAR-T to market

https://pharmaphorum.com/news/novartis-on-track-to-be-first-car-t-to-market/

After taking lead in CAR-T, Cellectis drug snapped up by Pfizer and Servier

https://pharmaphorum.com/news/after-taking-lead-in-car-t-cellectis-drug-snapped-up-by-pfizer-and-servier/

Close in 10 seconds

Pharmaphorum.com

Search